Related Experiment Videos
Clinical pharmacogenetics in pediatric patients
Anwar Husain1, Jennifer A Loehle, David W Hein
1University of Louisville, Department of Pharmacology & Toxicology and James Graham Brown Center, School of Medicine, Louisville, KY, USA.
Pharmacogenomics
|November 6, 2007
Summary
Pediatric pharmacogenetics offers personalized medicine for children, addressing unique developmental factors affecting drug responses. This approach can prevent adverse drug reactions and optimize treatment for conditions like asthma and ADHD.
Area of Science:
- Pharmacogenetics
- Pediatric Pharmacology
- Genomics in Medicine
Background:
- Children's drug response is complicated by developmental changes (ontological phenotypes).
- Historically, pediatric prescribing has been empirical, lacking personalized genetic insights.
- Pharmacogenetics can guide safer and more effective medication choices for pediatric patients.
Purpose of the Study:
- To highlight the importance of pharmacogenetics in pediatric medicine.
- To demonstrate how pharmacogenetic data can improve drug selection and safety in children.
- To illustrate clinical applications of pediatric pharmacogenetics.
Main Methods:
- Review of existing pediatric pharmacogenetic literature.
- Analysis of clinical examples in pediatric pharmacogenetics.
- Focus on specific pediatric conditions: transplantation, asthma, leukemia, and ADHD.
Main Results:
- Pharmacogenetic information can identify children at risk for adverse drug events.
- Personalized genetic data aids in selecting optimal therapeutic agents for pediatric patients.
- Selective clinical examples demonstrate pharmacogenetic applications in pediatric care.
Conclusions:
- Pediatric pharmacogenetics is crucial for advancing personalized medicine in children.
- Implementing pharmacogenetic insights can significantly improve pediatric patient outcomes.
- Further large-scale, multisite studies are needed to fully realize the potential of pediatric pharmacogenetics.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...